Journal
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
Volume 120, Issue 1, Pages 121-129Publisher
ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2020.08.001
Keywords
Adrenal venous sampling; Plasma renin activity; Primary aldosteronism
Categories
Ask authors/readers for more resources
This article summarizes the internationally accepted standards and clinical recommendations for the detection and diagnosis of primary aldosteronism, providing updated information and protocols recognized as internationally acceptable. The importance of not always withdrawing or adjusting antihypertensive medication on the first patient visit during screening, as well as the unnecessary need for further confirmatory testing in certain scenarios, is emphasized.
Background: To update information about the internationally accepted standards and clinical recommendations for the detection and diagnosis of primary aldosteronism (PA). Methods: The Taiwan Society of Aldosteronism (TSA) Task Force reviewed the latest literature and reached a consensus after group meetings. The nine critical issues were recognized to provide updated information and internationally acceptable protocols. Results: When screening for PA by using the plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio (ARR), withdrawal or adjustment of antihypertensive medication is not always necessary on the first patient visit. Hypokalemia should be corrected before ARR screening. In spontaneous hypokalemia, plasma renin below detection levels, and PAC higher than 20 ng/dL (550 pmol/L), further confirmatory testing is unnecessary for PA diagnosis. Direct renin concentration (DRC) could be used for PA diagnosis if PRA is unavailable. Although additional confirmatory tests are suggested, the result of a single test is still reliable. For patient safety, discontinuation or adjustment of antihypertensive medications is indicated before adrenal venous sampling (AVS). ACTH could be beneficial for successful adrenal vein cannulation but is not necessary for determining lateralization in AVS. Simultaneous technique is preferred for AVS. Adrenal NP-59 scintigraphy integrated with SPECT/CT could guide PA management. Conclusion: With introduction of these new concepts to the clinicians, we expect better identification, management and treatment of PA patients. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available